Progyny (PGNY) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Progyny

NasdaqGS•Healthcare•Healthcare Plans

$27.01-0.37(-0.01%)After hours

Market Cap

$2.12B

P/E

27.0x

P/S

1.6x

P/B

4.7x

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

How this company scores

GoodMetricSide Score: 75/100

Strongest: Profitability (21/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability21/25

Growth21/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality18/25

Strengths

High ROERising earningsInterest easily coveredCash-backed earnings

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 27.0x5y range 20.3x – 95.5x

Currently below its 20-quarter median.

P/S · 1.6x5y range 1.1x – 10.5x

Currently below its 20-quarter median.

P/B · 4.7x5y range 3.1x – 22.1x

Price & Volume

Market Cap $2.12B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.31B
Q. Revenue: $350.51M
TTM EBITDA: $117.87M
TTM Op. Income: $112.13M
Q. Op. Income: $40.00M
TTM Net Income: $78.63M
Q. Net Income: $28.05M
EPS: $0.36
Shares Out.: $78.17M

$1.31B in TTM revenue grew 5.5% YoY, reaching $350.51M last quarter. TTM EBITDA of $117.87M and TTM operating income of $112.13M show growth is flowing through to the bottom line. TTM net income of $78.63M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 25.5%
EBITDA Margin: 11.9%
Op. Margin: 11.4%
Net Margin: 8.0%

Op. margin of 11.4% is up 4.1% YoY — cost efficiency is improving. Net margin at 8.0% and gross margin of 25.5% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 27.0x
P/S Ratio: 1.6x
P/B Ratio: 4.7x

At 27.0x P/E, the stock trades within typical market levels. P/S of 1.6x and P/B of 4.7x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 24% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $715.84M
Cash: $152.63M
Long-Term Debt: N/A
Book Value: $453.26M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $50.42M
TTM Free Cash Flow: $178.38M
FCF Margin: 13.6%
FCF / Net Income: 2.3

TTM FCF of $178.38M on $50.42M in operating cash flow. The FCF / Net Income ratio of 2.3x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 3 consecutive quarters — a weakening trend.